Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator to manufacture the ...

Zydus Lifesciences receives USFDA approval to manufacture generic Niacin extended-release tablets for lowering cholesterol.

Statin use in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma is associated with improved cancer ...

A new study suggests that people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) may live longer ...

Treating high cholesterol quickly and aggressively after a heart attack may help prevent thousands of new heart attacks and ...

Cardiologists have known for more than three decades that statin-type cholesterol-lowering drugs can lower levels of ubiquinone. Most people know ubiquinone by the name coenzyme Q10 or CoQ10.

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

A new study found that adding a second drug early after a heart attack may save lives. Those who added ezetimibe to a statin ...

Ahmedabad: Zydus Lifesciences Limited has announced that the company has received final approval from the United States Food ...

Lowering cholesterol triggers other health problems. Mostly false. Prior to the introduction of statins four decades ago, ...

It's estimated that over 90 million adults in the United States take a statin drug to reduce their cholesterol levels and lower their risk for heart disease, which can lead to heart attacks or ...